These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26596819)

  • 1. What We Can Learn from "Super-responders".
    Proclemer A; Muser D; Facchin D
    Card Electrophysiol Clin; 2015 Dec; 7(4):781-8. PubMed ID: 26596819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Resynchronization Therapy: How to Decrease Nonresponders.
    Tolosana JM; Mont L
    Card Electrophysiol Clin; 2015 Dec; 7(4):789-96. PubMed ID: 26596820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What We Can Learn from "Super-responders".
    Proclemer A; Muser D; Facchin D
    Heart Fail Clin; 2017 Jan; 13(1):225-232. PubMed ID: 27886927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.
    Manne M; Rickard J; Varma N; Chung MK; Tchou P
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):970-7. PubMed ID: 23718783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy.
    Zecchin M; Proclemer A; Magnani S; Vitali-Serdoz L; Facchin D; Muser D; Nordio A; Barbati G; Puggia I; Sinagra G; Proclemer A
    Europace; 2014 Mar; 16(3):363-71. PubMed ID: 24189477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yield of left ventricular dyssynchrony by gated SPECT MPI in patients with heart failure prior to implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator: Characteristics and prediction of cardiac outcome.
    Zafrir N; Bental T; Strasberg B; Solodky A; Mats I; Gutstein A; Kornowski R
    J Nucl Cardiol; 2017 Feb; 24(1):122-129. PubMed ID: 26563336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators.
    Sze E; Daubert JP
    Card Electrophysiol Clin; 2015 Dec; 7(4):695-707. PubMed ID: 26596812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
    Daubert JC; Martins R; Leclercq C
    Card Electrophysiol Clin; 2015 Dec; 7(4):709-20. PubMed ID: 26596813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.
    Schneider PM; Pellegrini CN; Wang Y; Fein AS; Reynolds MR; Curtis JP; Masoudi FA; Varosy PD
    Am J Cardiol; 2014 Jun; 113(12):2052-6. PubMed ID: 24793671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraordinarily favorable left ventricular reverse remodeling through long-term cardiac resynchronization: super-response to cardiac resynchronization.
    Çelebi Ö; Knaus T; Blaschke F; Habedank D; Döhner W; Nitardy A; Stockburger M
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):870-6. PubMed ID: 22553930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy for patients with cardiac sarcoidosis.
    Sairaku A; Yoshida Y; Nakano Y; Hirayama H; Maeda M; Hashimoto H; Kihara Y
    Europace; 2017 May; 19(5):824-830. PubMed ID: 28339577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
    Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
    Card Electrophysiol Clin; 2015 Dec; 7(4):755-64. PubMed ID: 26596817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
    Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
    Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.